Salient Capital Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-3,110
| Closed | -$850K | – | 215 |
|
|
2017
Q1 | $850K | Buy |
3,110
+500
| +19% | +$137K | 0.02% | 141 |
|
|
2016
Q4 | $740K | Buy |
2,610
+50
| +2% | +$14.2K | 0.01% | 145 |
|
|
2016
Q3 | $801K | Buy |
2,560
+200
| +8% | +$62.6K | 0.02% | 128 |
|
|
2016
Q2 | $571K | Buy |
2,360
+400
| +20% | +$96.8K | 0.01% | 160 |
|
|
2016
Q1 | $510K | Buy |
1,960
+400
| +26% | +$104K | 0.01% | 169 |
|
|
2015
Q4 | $478K | Buy |
1,560
+536
| +52% | +$164K | 0.01% | 181 |
|
|
2015
Q3 | $299K | Buy |
+1,024
| New | +$299K | 0.01% | 199 |
|